identified TCF1+ PD‐1+ cells in both the blood and TILs of melanoma patients, which display characteristics of both exhausted and central memory T (Tcm) cells and mediate the proliferative response to immunotherapy.[105] Yamauchi et al. The gene discussed is TCF7; the disease is melanoma.